WATCH LIVE

House Committee on Oversight holds hearing on attempted assassination on Donald Trump. Stream now on News 12 New York.

ALERT CENTER: Pfizer to develop Omicron-specific vaccine by March

Rockland-based Pfizer saying an Omicron-specific vaccine will be ready in several weeks.

News 12 Staff

Jan 10, 2022, 5:26 PM

Updated 923 days ago

Share:

Rockland-based Pfizer saying an Omicron-specific vaccine will be ready in several weeks.
On CNBC today, Pfizer CEO Albert Bourla said that the Omicron-specific vaccine will be ready in March and that the company has already begun manufacturing doses.
Bourla says Pfizer's primary vaccine with a booster shot increases antibody levels capable of fighting off Omicron 25-fold. Whether that's enough will be looked at over the next several weeks.
A Pfizer spokesperson tells News 12 that in the event that their current vaccine and booster are not found to protect against the Omicron variant or other future variants, Pfizer expects “to be able to develop and produce a tailor-made vaccine against that variant in approximately 100 days, subject to regulatory approval."


More from News 12